Home Stargazer Pharmaceuticals

Stargazer Pharmaceuticals

In operation
Series A
Ophthalmic Disease Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Stargazer Pharmaceuticals, Inc. is an ophthalmic biotechnology company focused on developing a new therapeutic approach for Stargardt disease, an inherited orphan retinal disorder with unmet medical needs.
Stargazer Pharmaceuticals, Inc.
Boston,Massachusetts,United States of America
less than 15 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Ophthalmology Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs Prescription Drug